Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 4,200 shares, a decline of 49.4% from the October 15th total of 8,300 shares. Based on an average daily trading volume, of 9,400 shares, the days-to-cover ratio is currently 0.4 days.

Algernon Pharmaceuticals Price Performance

Shares of OTCMKTS:AGNPF opened at $0.06 on Wednesday. The company’s 50-day moving average price is $0.06 and its two-hundred day moving average price is $0.08. Algernon Pharmaceuticals has a one year low of $0.04 and a one year high of $0.12.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.